Convergent evolution of berberine biosynthesis
- PMID: 39612339
- PMCID: PMC11606445
- DOI: 10.1126/sciadv.ads3596
Convergent evolution of berberine biosynthesis
Abstract
Berberine is an effective antimicrobial and antidiabetic alkaloid, primarily extracted from divergent botanical lineages, specifically Coptis (Ranunculales, early-diverging eudicot) and Phellodendron (Sapindales, core eudicot). In comparison with its known pathway in Coptis species, its biosynthesis in Phellodendron species remains elusive. Using chromosome-level genome assembly, coexpression matrix, and biochemical assays, we identified six key steps in berberine biosynthesis from Phellodendron amurense, including methylation, hydroxylation, and berberine bridge formation. Notably, we discovered a specific class of O-methyltransferases (NOMT) responsible for N-methylation. Structural analysis and mutagenesis of PaNOMT9 revealed its unique substrate-binding conformation. In addition, unlike the classical FAD-dependent berberine bridge formation in Ranunculales, Phellodendron uses a NAD(P)H-dependent monooxygenase (PaCYP71BG29) for berberine bridge formation, originating from the neofunctionalization of tryptamine 5-hydroxylase. Together, these findings reveal the convergence of berberine biosynthesis between Coptis and Phellodendron and signify the role of the convergent evolution in plant specialized metabolisms.
Figures





References
-
- Wang Y., Tong Q., Ma S. R., Zhao Z. X., Pan L. B., Cong L., Han P., Peng R., Yu H., Lin Y., Gao T. L., Shou J. W., Li X. Y., Zhang X. F., Zhang Z. W., Fu J., Wen B. Y., Yu J. B., Cao X., Jiang J. D., Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduct. Target. Ther. 6, 77 (2021). - PMC - PubMed
-
- Zhang Y., Gu Y., Ren H., Wang S., Zhong H., Zhao X., Ma J., Gu X., Xue Y., Huang S., Yang J., Chen L., Chen G., Qu S., Liang J., Qin L., Huang Q., Peng Y., Li Q., Wang X., Kong P., Hou G., Gao M., Shi Z., Li X., Qiu Y., Zou Y., Yang H., Wang J., Xu G., Lai S., Li J., Ning G., Wang W., Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat. Commun. 11, 5015 (2020). - PMC - PubMed
-
- Wang S., Ren H., Zhong H., Zhao X., Li C., Ma J., Gu X., Xue Y., Huang S., Yang J., Chen L., Chen G., Qu S., Liang J., Qin L., Huang Q., Peng Y., Li Q., Wang X., Zou Y., Shi Z., Li X., Li T., Yang H., Lai S., Xu G., Li J., Zhang Y., Gu Y., Wang W., Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: A double blinded placebo controlled randomized study. Gut. Microbes 14, 2003176 (2022). - PMC - PubMed
-
- Ekstrom M., Ferreira D., Chang S., Louw S., Johnson M. J., Eckert D. J., Fazekas B., Clark K. J., Agar M. R., Currow D. C., Australian National Palliative Care Clinical Studies Collaborative , Effect of regular, low-dose, extended-release morphine on chronic breathlessness in chronic obstructive pulmonary disease: The BEAMS Randomized Clinical Trial. JAMA 328, 2022–2032 (2022). - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources